AskBio Announces 11 Presentations at the European Society of Gene and Cell Therapy 31st Annual Meeting 2024 [Financial Post (Toronto, Ontario, Canada)]
BAYER AG S/ADR (BAYRY)
NASDAQ:AMEX Investor Relations:
investor.bayer.com
Company Research
Source: Financial Post
Research Triangle Park, N.C., Oct. 17, 2024 (GLOBE NEWSWIRE) — Two oral presentations and nine poster presentations will highlight exciting progress in AskBio's clinical and pre-clinical pipeline and advancements in the company's manufacturing technologies Alongside recent clinical program milestones, presentations demonstrate AskBio's commitment to advancing end-to-end capabilities and goal of delivering breakthrough therapies Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, will deliver 11 presentations offering insights into the research and development of adeno-associated virus (AAV) therapies for a range of diseases as well as advancements in manufacturing technologies, at the European Society of Gene and Cell Therapy (ESGCT) 31 st Annual Meeting taking place October 22–25, 2024, in Rome, Italy. “Our presence at ESCGT this year demonstrates our commitment to strengthening our end-to-
Show less
Read more
Impact Snapshot
Event Time:
BAYRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BAYRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BAYRY alerts
High impacting BAYER AG S/ADR news events
Weekly update
A roundup of the hottest topics
BAYRY
News
- Insecticides Market Size Expected to Reach USD 34.74 Billion by 2033 [Yahoo! Finance]Yahoo! Finance
- Exacto Announces David Hollinrake as Chief Executive Officer [Yahoo! Finance]Yahoo! Finance
- Pivot Bio Names Jason Hoag Head of North American Commercial Distribution [Yahoo! Finance]Yahoo! Finance
- 3rd Philadelphia Jury Finds in Favor of Monsanto in Roundup Trial [Yahoo! Finance]Yahoo! Finance
- Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio [Yahoo! Finance]Yahoo! Finance